Sodium Iodide I 131 Diagnostic
NDC 65174-461, Sodium Iodide I 131, capsule, from Jubilant DraxImage Inc., dba Jubilant Radiopharma.
- Product NDC
- 65174-461
- Status
- Listed
- Labeler
- Jubilant DraxImage Inc., dba Jubilant Radiopharma
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021305
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65174-461 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM IODIDE I-131100 mCi/1
Pharmacologic classes
Radioactive Therapeutic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65174-461-05 | 65174046105 | 5 CAPSULE in 1 VIAL (65174-461-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/46b8d7ba-432d-d610-84f2-550bf9d0bae3
Use it
Look up 65174-461 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65174-461 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65174-461. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.